William E. Fahl
13Patents
4h-index
16Co-inventors
57Inventor score
Filing activity: Aug 26, 1994 → Jan 4, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6136605A | Glutathione S-transferase isoforms | Human Necessities | 9 | Expired |
| US7314959B2 | Amino thiol compounds and compositions for use in conjunction with cancer therapy | Chemistry; Metallurgy | 6 | Expired |
| US7045550B2 | Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy | Performing Operations; Transporting | 5 | Expired |
| US7531562B2 | Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy | Human Necessities | 5 | Expired |
| US8461136B2 | Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy | Human Necessities | 3 | Active |
| US9839638B2 | Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy | Human Necessities | 3 | Active |
| US8247457B2 | Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy | Human Necessities | 1 | Active |
| US7414154B2 | Polyamine compounds and compositions for use in conjunction with cancer therapy | Chemistry; Metallurgy | 0 | Expired |
| US9458100B2 | Synthesis and growth regulatory activity of a prototype member of a new family of aminothiol radioprotectors | Chemistry; Metallurgy | 0 | Active |
| US6040424A | Protein and gene for antioxidant response | Human Necessities | 0 | Expired |
| US11197836B2 | Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy | Human Necessities | 0 | Active |
| US8114914B2 | Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy | Human Necessities | 0 | Active |
| US11690813B2 | Aminothiol reduction of ischemia-reperfusion-induced cell death | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.